Clinical Lung Cancer
Clinical Lung Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 78. It has an SJR impact factor of 1,515 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,515.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,515
H-index
78
Docs (year)
157
Docs 3y
501
Total refs
4432
Cites 3y
1660
Citable 3y
468
Cites/Doc 2y
3.25
Ref/Doc
28.23
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
2006 Highlights From: The Third International Association for the Study of Lung Cancer/American Society of Clinical Oncology/European Society of Medical Oncology International Conference on Molecular-Targeted Therapies in Lung Cancer Taormina, Sicily
View moreTherapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications
View moreCommentary on "Growth-Stimulating Pathways in Lung Cancer: Implications for Targets of Therapy"
View moreCommentary on "Endoscopic Laser Ablation as Palliative Treatment of Endobronchial, Nonresectable, or Recurrent Lung Cancer: Assessment of its Impact on Quality of Life"
View moreCommentary on "Effectiveness of Radiation Therapy on Non-Small-Cell Lung Cancer"
View moreClinical Development of Vandetanib: A Review of Ongoing Phase III Clinical Trials in Advanced NSCLC
View moreCanadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer -Rationale and Protocol Design for the Ontario Clinical Oncology Gr
View moreBcl-2 as a Target for Overcoming Chemoresistance in Small-Cell Lung Cancer
View moreApplication of Genomics and Proteomics to Developments of Novel Therapies for Lung Cancer
View moreActivity of ZD1839 (Gefitinib, Iressa‚Ñ¢) in Previously Treated Patients with Recurrent and Advanced non - small-Cell Lung Cancer
View moreA Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary Adenocarcinoma
View more2008 Highlights from: The IASLC-ESMO 1st European Lung Cancer Conference; Geneva, Switzerland; April 2008
View more2007 Highlights from: the 24th Annual Meeting of the American Association for Cancer Research Los Angeles, CA; April 14-18, 2007
View more1999 Highlights From: 10th European Cancer Conference, Vienna, Austria; 17th Chemotherapy Foundation Symposium, New York City, New York
View more2006 Highlights From: The European Society for Medical Oncology Congress Istanbul, Turkey; Sept. 29-Oct. 3, 2006 International Association for the Study of Lung Cancer Early Invasive Lung Cancer Workshop Turin, Italy; Sept. 25-26, 2006
View more2006 Highlights From: 7th International Lung Cancer Congress Workshop Maui, HI; June 28-July 1, 2006
View more2005 Highlights From: First Annual Lung Cancer Symposium, New York, NY, November 2005
View more2002 Highlights From: 27th Congress of the European Society for Medical Oncology; Nice, France October 18-22, 2002
View more2001 Highlights From: The 2001 European Cancer Conference Lisbon, Portugal October 21-25, 2001
View more2001 Highlights From: 37th Annual American Society of Clinical Oncology Meeting San Francisco, CA May 12-15, 2001
View more2001 Highlights From: 37th Annual American Society of Clinical Oncology Meeting San Francisco, CA May 12-15, 2001
View more2001 Highlights From: 2nd International Lung Cancer Congress Kauai, Hawaii July 18-21, 2001
View more2000 Highlights From: 9th World Conference on Lung Cancer; Tokyo, Japan September 2000
View more2000 Highlights From: 36th Annual ASCO Meeting; New Orleans, LA May 2000
View more